Researchers find Epstein Barr-like virus infects and may cause cancer in dogs
More than 90 percent of humans have antibodies to the Epstein Barr virus. Best known for causing mononucleosis, or "the kissing disease," the virus has also been implicated in more serious conditions, including Hodgkin's, non-Hodgkin's and Burkitt's lymphomas. Yet little is known about exactly how EBV triggers these diseases.
Now a team of researchers from the University of Pennsylvania School of Veterinary Medicine and Penn's Perelman School of Medicine has the first evidence that an Epstein Barr-like virus can infect and may also be responsible for causing lymphomas in man's best friend.
The findings suggest that domestic dogs possess a similar biology to humans with respect to EBV infection. That could allow scientists to study dogs to help uncover the mechanisms by which EBV leads to cancer in certain people.
"There are no large-animal spontaneous models of EBV infection and virus-associated disease, and most studies investigating viral disease are performed in non-human primates, which are very expensive," said Nicola Mason, senior author of the study and an assistant professor of medicine and pathobiology at Penn Vet. "Discovering that dogs can get infected with this virus like people do may provide us with a long-sought-after model for EBV-associated disease."
Mason's team at Penn Vet included Shih-Hung Huang, Philip Kozak, Jessica Kim, George Habineza-Ndikuyeze, Charles Meade, Anita Gaurnier-Hausser and Reema Patel. The team worked closely with Erle Robertson, professor of microbiology at the Perelman School of Medicine.
Their work was published online March 8 in the journal Virology.
In humans, the Epstein Barr virus infects B cells. After an acute phase of infection, of which many people are not even aware, the virus goes into a latent phase. Most people show no symptoms during this phase, but, in some, EBV promotes unnatural growth of B cells, which contributes to the development of lymphoma.
Meanwhile, dogs develop lymphomas that share some characteristics with the human equivalents. These conditions are relatively common in certain breeds. In golden retrievers, for instance, one out of every eight dogs develops lymphoma.
Yet, "the paradigm up until now was that EBV only infects humans," Mason said. "It is an extremely successful virus, and most people are infected. Since humans and domestic dogs have cohabited for around 15,000 years, we hypothesized that the virus may have adapted to another host. "
To search for evidence of infection, Mason and colleagues obtained samples of blood from client-owned dogs of various breeds brought to Penn Vet for care. In 48 dogs with lymphoma and 41 without the disease, the researchers first looked to see if the pets had antibodies against proteins specific to the EBV capsid, the protein shell of the virus. The test is nearly identical to one that physicians use to detect exposure to EBV in humans.
The researchers observed that eight of the dogs with lymphoma and three of those without it had high levels of antibodies against EBV proteins, indicating that a portion of the dogs had been exposed to a virus very similar to EBV.
While the presence of antibodies confirms that a dog has been exposed to a virus, the team wanted to know whether the virus had a direct association with the tumors in dogs with lymphoma. Finding viral elements, including DNA, within lymphomas in humans is an indication that the tumor is associated with the virus, therefore Penn researchers looked to see if they could find virus in the dog tumors.
Using the polymerase chain reaction, which amplifies specific DNA sequences, the researchers analyzed lymph nodes of dogs with and without B cell lymphoma. In two dogs with lymphoma, they were able to identify a portion of DNA very similar to a sequence in EBV. They found no evidence of the same DNA in the healthy dogs.
They repeated similar tests with other stretches of EBV DNA, finding evidence of EBV-like DNA in the cancer cells of three of nine dogs with lymphoma. They also identified a virus-associated protein in the malignant lymph nodes of two of nine dogs with lymphoma.
Finally, examining cancerous B cells under an electron microscope revealed what appeared to be viral particles, similar to what what has been seen in the tumor cells of humans with EBV-linked lymphomas.
Taken together, the researchers' discoveries indicate that some dogs are naturally infected with a virus similar or identical to EBV and that, as in humans, the virus appears linked in certain cases with canine lymphomas.
That such a large percentage of humans are exposed to EBV and yet only a small fraction develop cancers indicates that there may be a genetic component to EBV-associated cancer susceptibility.
"With additional studies within certain breeds of dog," Mason said, "we hope to provide insights into genetic factors that may predispose to virus associated lymphoma. Furthermore, this spontaneous dog model may help us evaluate new treatments for EBV-related lymphomas or investigate strategies to prevent those cancers from developing in the first place."
Provided by
University of Pennsylvania
-
NIH scientists outline steps toward Epstein-Barr virus vaccine
Nov 02, 2011 |
not rated yet |
0
-
Study offers first clinical evidence of anti-cancer drug triggering viral infection
Apr 12, 2010 |
not rated yet |
0
-
Clue found to Epstein-Barr virus' ability to form and sustain tumors
Sep 05, 2006 |
not rated yet |
0
-
A tricky tumor virus
Jan 17, 2008 |
not rated yet |
0
-
Researchers reveal Epstein-Barr virus protein contributes to cancer
Oct 03, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
New fluorescent tools for cancer diagnosis
In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...
Cancer
May 24, 2013 |
not rated yet |
0
Modulating the immune system to combat metastatic cancer
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...
Cancer
May 24, 2013 |
5 / 5 (1) |
0
Scientists put bowel cancer under the microscope
Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.
Cancer
May 24, 2013 |
5 / 5 (1) |
0
Researcher identifies breast cancer fighting hormone
Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.
Cancer
May 24, 2013 |
5 / 5 (2) |
0
Ground breaking cancer research finds immune system link
(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.
Cancer
May 24, 2013 |
5 / 5 (4) |
0
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
Seniors more likely to crash when driving with pet, study finds
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
Death highest in heart failure patients admitted in January, on Friday, and overnight
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
Feds fight morning-after pill age ruling in NY
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...